type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM#67838ClinicalTrials.gov
• Does Early Weight Loss Following Laparoscopic Sleeve Gastrectomy Affect Long-term Outcomes#125982ClinicalTrials.gov
• To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function#127768ClinicalTrials.gov
• Serum Uric Acid as a Biomarker for Incident Type 2 Diabetes Mellitus: A 6-Year Cohort Study in Qatar.#140614NCBI PubMed Central
• Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients#146406ClinicalTrials.gov
• Nurse-Led Psychoeducational Interventions for Glycemic and Psychosocial Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.#170557NCBI PubMed Central
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects#172516ClinicalTrials.gov
• The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.#184751ClinicalTrials.gov
• 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)#208411ClinicalTrials.gov
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM#226224ClinicalTrials.gov
• DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM#230317ClinicalTrials.gov
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes#18542ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin#208396ClinicalTrials.gov
• Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated#67855ClinicalTrials.gov
• Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function#136208ClinicalTrials.gov
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study#143799ClinicalTrials.gov
• Association between type 2 diabetes mellitus and psychosocial burdens in older adults in Germany: findings from the longitudinal Gesundheit 65+ study.#171923NCBI PubMed Central
• A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)#172494ClinicalTrials.gov
• Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)#195528ClinicalTrials.gov
• Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice#216989ClinicalTrials.gov
• Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali#249534ClinicalTrials.gov
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus#162443ClinicalTrials.gov
• Joint Modeling of Fasting Blood Sugar Changes and Cardiovascular Disease Progression in Type‐2 Diabetes Mellitus Patients: A Retrospective Cohort Study.#15186NCBI PubMed Central
• Video Training to Reduce Insulin Administration Errors#67800ClinicalTrials.gov
• Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg#162408ClinicalTrials.gov
• Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride#238323ClinicalTrials.gov
• Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT)#249520ClinicalTrials.gov
• A flexible wearable glucose sensor for noninvasive diabetes screening: Functional equivalence and model interpretability#233502Research Online
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)#143809ClinicalTrials.gov
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin#121287ClinicalTrials.gov
• Barriers and facilitators for implementation of lifestyle related blended care interventions for overweight, obesity and type 2 diabetes mellitus: a scoping review.#143507NCBI PubMed Central
• A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use#143724ClinicalTrials.gov
• Association between time-domain heart rate variability, diastolic dysfunction and unplanned readmission to cardiovascular department in older type 2 diabetes mellitus patients.#214220NCBI PubMed Central
• Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d#230368ClinicalTrials.gov
• Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability#267988ClinicalTrials.gov
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together#208420ClinicalTrials.gov
• Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.#234382ClinicalTrials.gov
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors#201724ClinicalTrials.gov
• Impact of type 2 diabetes mellitus on in-hospital outcomes in patients with ST-elevation myocardial infarction: A nationwide study in Germany.#9635PubMed
• Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.#138557NCBI PubMed Central
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.#140948ClinicalTrials.gov
• The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients#143755ClinicalTrials.gov
• Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State#201744ClinicalTrials.gov
• Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.#226196ClinicalTrials.gov
• Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin#234384ClinicalTrials.gov
• A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate#216997ClinicalTrials.gov
• Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery#172449ClinicalTrials.gov
• SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Comparative Review of Efficacy, Cardiovascular and Renal Benefits, and Cost#179740BYU ScholarsArchive
• Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets#18548ClinicalTrials.gov
• Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF#127792ClinicalTrials.gov